STEVEN DEMETRIUS SARIS, MD
Osteopathic Medicine at Valley Rd, Ardmore, PA

License number
Pennsylvania MD021894
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
130 Valley Rd, Ardmore, PA 19003
Phone
(610) 649-3150

Personal information

See more information about STEVEN DEMETRIUS SARIS at radaris.com
Name
Address
Phone
Steven Saris
130 Valley Rd #12, Ardmore, PA 19003
(610) 428-1092
Steven Saris, age 72
130 Valley Rd, Ardmore, PA 19003
(610) 649-3150
Steven D Saris
100 Church Rd, Ardmore, PA 19003
(610) 649-7553
Steven D Saris
100 Church St, Media, PA 19003
(610) 649-7553
Steven D Saris, age 72
130 Valley Rd, Ardmore, PA 19003
(610) 649-7350
(610) 649-3150

Professional information

Steven D Saris Photo 1

Dr. Steven D Saris, Ardmore PA - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
130 Valley Rd, Ardmore 19003
(610) 649-3150 (Phone)
Certifications:
Internal Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
130 Valley Rd, Ardmore 19003
Bryn Mawr Hospital
130 South Bryn Mawr Ave, Bryn Mawr 19010
Education:
Medical School
Hahnemann University
Graduated: 1977
Med College Penn
Graduated: 1980


Steven Saris Photo 2

Method Of Reducing Serum Uric Acid And/Or Increasing Renal Uric Acid Clearance With Thromboxane Synthetase Inhibitor Inhibitor And/Or Thromboxane Receptor Antagonist

US Patent:
5021448, Jun 4, 1991
Filed:
Feb 22, 1990
Appl. No.:
7/483160
Inventors:
Anthony J. Piraino - Media PA
Steven D. Saris - Ardmore PA
Assignee:
Ciba-Geigy Corporation - Ardsley NY
International Classification:
A61K 31415, A61K 3140, A61K 3134, A61K 31335, A61K 31265, A61K 3118, A61K 31135, A61K 31095, A61K 3110, A61K 31075, A61K 31045, A61K 3105, A61K 3144
US Classification:
514415
Abstract:
A method of reducing serum uric acid and/or increasing renal clearance of uric acid in a mammal in need thereof comprising administering to such mammal a uricosuric effective amount of a thromboxane synthetase inhibitor, a thromboxane receptor antagonist, or both in a combined uricosuric effective amount is disclosed. Compositions having one or more of the foregoing in combination with one or more known uricosurics are also set forth.